1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Sources
2.3. Research Design
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. AI IN CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
5.1. Introduction
5.2. BREAST CANCER
5.3. LUNG CANCER
5.4. PROSTATE CANCER
5.5. COLORECTAL CANCER
5.6. SKIN CANCER
5.7. OTHERS
6. AI IN CANCER DIAGNOSTICS MARKET, BY APPLICATION
6.1. Introduction
6.2. TUMOR DETECTION AND CLASSIFICATION
6.3. TREATMENT PLANNING
6.4. IMAGE ANALYSIS
6.5. GENOMIC ANALYSIS
6.6. OTHERS
7. AI IN CANCER DIAGNOSTICS MARKET, BY END-USER
7.1. Introduction
7.2. HOSPITALS AND CLINICS
7.3. DIAGNOSTIC CENTERS
7.4. RESEARCH INSTITUTES
7.5. OTHERS
8. AI IN CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Taiwan
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. GOOGLE LLC (ALPHABET INC.)
10.2. IBM CORPORATION
10.3. MICROSOFT CORPORATION
10.4. PAIGE.AI, INC.
10.5. TEMPUS LABS, INC.
10.6. PATHAI, INC.
10.7. INSPIRATA, INC.
10.8. PROSCIA INC.
10.9. IBEX MEDICAL ANALYTICS LTD.
10.10. ZEBRA MEDICAL VISION LTD.